These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27600440)
1. Dynamic functionality and static changes of retinal vessels in diabetic patients treated with intravitreal ranibizumab. Benatti L; Corvi F; Tomasso L; Darvizeh F; La Spina C; Querques L; Bandello F; Querques G Acta Diabetol; 2017 Jan; 54(1):39-43. PubMed ID: 27600440 [TBL] [Abstract][Full Text] [Related]
2. Impact of Intravitreal Ranibizumab on Vessel Functionality in Patients With Retinal Vein Occlusion. Corvi F; La Spina C; Benatti L; Querques L; Lattanzio R; Bandello F; Querques G Am J Ophthalmol; 2015 Jul; 160(1):45-52.e1. PubMed ID: 25896458 [TBL] [Abstract][Full Text] [Related]
3. Diameter of retinal vessels in patients with diabetic macular edema is not altered by intravitreal ranibizumab (lucentis). Terai N; Haustein M; Siegel A; Stodtmeister R; Pillunat LE; Sandner D Retina; 2014 Jul; 34(7):1466-72. PubMed ID: 24457978 [TBL] [Abstract][Full Text] [Related]
4. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab. Baget-Bernaldiz M; Romero-Aroca P; Bautista-Perez A; Mercado J Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment. Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308 [TBL] [Abstract][Full Text] [Related]
6. EFFECTS OF INTRAVITREAL RANIBIZUMAB AND BEVACIZUMAB ON THE RETINAL VESSEL SIZE IN DIABETIC MACULAR EDEMA. Kurt MM; Çekiç O; Akpolat Ç; Elçioglu M Retina; 2018 Jun; 38(6):1120-1126. PubMed ID: 28520638 [TBL] [Abstract][Full Text] [Related]
8. A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema. Wiley HE; Thompson DJ; Bailey C; Chew EY; Cukras CA; Jaffe GJ; Lee RW; Loken EK; Meyerle CB; Wong W; Ferris FL Ophthalmology; 2016 Apr; 123(4):841-9. PubMed ID: 26875003 [TBL] [Abstract][Full Text] [Related]
9. Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema. Srinivas S; Verma A; Nittala MG; Alagorie AR; Nassisi M; Gasperini J; Sadda SR Am J Ophthalmol; 2020 Mar; 211():183-190. PubMed ID: 31758926 [TBL] [Abstract][Full Text] [Related]
10. Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE. Pieramici DJ; Wang PW; Ding B; Gune S Ophthalmology; 2016 Jun; 123(6):1345-50. PubMed ID: 26992841 [TBL] [Abstract][Full Text] [Related]
11. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema. Okamoto M; Yamashita M; Ogata N Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689 [TBL] [Abstract][Full Text] [Related]
12. Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials. Domalpally A; Ip MS; Ehrlich JS Ophthalmology; 2015 Apr; 122(4):779-86. PubMed ID: 25601535 [TBL] [Abstract][Full Text] [Related]
13. Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema. Mori Y; Murakami T; Suzuma K; Ishihara K; Yoshitake S; Fujimoto M; Dodo Y; Yoshitake T; Miwa Y; Tsujikawa A PLoS One; 2017; 12(4):e0175809. PubMed ID: 28407012 [TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505 [TBL] [Abstract][Full Text] [Related]
15. Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema. Minami Y; Nagaoka T; Ishibazawa A; Yoshida A BMC Ophthalmol; 2017 Mar; 17(1):28. PubMed ID: 28292270 [TBL] [Abstract][Full Text] [Related]
16. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema. Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223 [TBL] [Abstract][Full Text] [Related]
17. VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema. Tetikoğlu M; Yüksel Z; Aktas S; Sağdik HM; Özcura F Int Ophthalmol; 2018 Dec; 38(6):2381-2388. PubMed ID: 29030794 [TBL] [Abstract][Full Text] [Related]